Application of Hildebrand Solubility Parameter to Identify Ethanol-Free Co-Solvent for Pediatric Formulation
Abstract
Formulation of active pharmaceutical ingredients into liquid dosage form is frequently limited by solubility issues. Ethanol is commonly used as a cosolvent to improve the solubility of drugs. Due to the incomplete expression of ethanol metabolizing enzyme in children under 6 years, several drug authorities such as WHO, EMA, and FDA recommend avoiding the use of ethanol in pediatric formulation whenever possible. In addition to that Muslim consumers are regulated by the halal practice where excessive use of ethanol in pharmaceutical products should be avoided. Thus, it is necessary to explore an alternative co-solvent to reduce the use of ethanol in the pediatric formulation. This study is aimed to identify an alternative co-solvent to ethanol that is safe for the pediatric using Hildebrand Solubility Parameter approach.
In this study, the solubility parameter of the model drug, MH2011, was determined using Hildebrand Solubility Parameter (HSP). The solubility parameter (δ) of MH2011 was determined using two approaches. The first method is by measuring the maximum solubility of the model drugs in the binary mixture of water and 1,4 dioxane. The second approach is by calculating solubility parameters based on Fedor’s group substitution method.
Using binary solvent blend, the MH2011 solubility parameter was identified to be approximately 14.0 (cal/cm3 )½. This value is in agreement with the result of the second approach using Fedor’s Group substitution method which is 14. 4 (cal/cm3) ½. With this data, an alternate co-solvent to substitute ethanol was explored. The studies also suggested that propylene glycol 7% v/v may give solubility power as those of ethanol 7% (v/v). This study suggested that Hildebrand’s Solubility Parameter can be applied to identify an alternate co-solvent to ethanol. This cosolvent is important for the research area where the alcohol-free formulation is preferred such as in halal pharmaceuticals and pediatric liquid formulation.
References
Afifi, M., Halim, A., Mahyeddin, Mohd, Salleh, M., Mohd, Ariff, I., Kashim, M., Azlin, Ahmad, A., & Nordin, Norhaslinda. (2014). Halal pharmaceuticals: legal, shri’ah issues and fatwa of drug, gelatine and alcohol. International Journal of Asian Social Science International, 4(412), 1176–1190.
Alserhan, B. A., Bayirli, M., & Zakzouk, F. (2020). Awareness towards Halal pharmaceuticals: an analysis of pharmacists’ views. International Journal of Islamic Marketing and Branding, 5(1), 43. https://doi.org/10.1504/ijimb.2020.109065
Alzeer, J., & Abou Hadeed, K. (2016). Ethanol and its Halal status in food industries. Trends in Food Science and Technology, 58(November), 14–20. https://doi.org/10.1016/j.tifs.2016.10.018
Annabi, C. A., & Wada, S. M. (2016). Halal pharmaceutical industry in Nigeria: A bitter pill to swallow. Journal of Emerging Economies and Islamic Research, 4(2), 67. https://doi.org/10.24191/jeeir.v4i2.9087
Bhatt, D. K., Gaedigk, A., Pearce, R. E., Leeder, J. S., & Prasad, B. (2017). Age-dependent protein abundance of cytosolic alcohol and aldehyde dehydrogenases in human liver. Drug Metabolism and Disposition, 45(9), 1044–1048. https://doi.org/10.1124/dmd.117.076463
Fedors, R. (1974). A method for estimating both solubility parameter and molar volume of liquids. Polymers Engineering and Sciences, 14(2), 147–154.
Peraturan Pemerintah Nomor 39 Tahun 2021 tentang Penyelenggaraan Bidang Jaminan Produk Halal (Indonesian government law no 39, 2021 regarding Halal Product Certification (2021).
Kaur, K., Osman, S., Kaur, S., & Singh, J. (2018). Is Halal a priority in purchasing cosmetics in Malaysia among Muslim Malaysian women? International Journal of Business, Economics and Law, 15(3), 19–25.
Laksitorini, M. D., Yathindranath, V., Xiong, W., Parkinson, F. E., Thliveris, J. A., & Miller, D. W. (2021). Impact of Wnt/β-catenin signaling on ethanol-induced changes in brain endothelial cell permeability. Journal of Neurochemistry, 157(4), 1118–1137. https://doi.org/10.1111/jnc.15203
Lim, T. Y., Poole, R. L., & Pageler, N. M. (2014). Propylene glycol toxicity in children. The Journal of Pediatric Pharmacology and Therapeutics, 19(4), 277–282. https://doi.org/10.5863/1551-6776-19.4.277
Majelis Ulama Indonesia. (2018). Fatwa Majelis Ulama Indonesia tentang penggunaan etanol/alkohol sebagai bahan obat (Indonesian Ulema Council fatwa on the use of ethanol in pharmaceuticals).
Markovic, M., Ben-Shabat, S., Aponick, A., Zimmermann, E. M., & Dahan, A. (2020). Lipids and lipid-processing pathways in drug delivery and therapeutics. International Journal of Molecular Sciences, 21(9). https://doi.org/10.3390/ijms21093248
Rahmah, D. R. (2019). Alcohol and khamr in fiqh based on science perspective. International Journal of Islamic Studies and Humanities, 2(1), 1–10. https://doi.org/10.26555/ijish.v2i1.859
Nayak, A. K., & Panigrahi, P. P. (2012). Solubility enhancement of etoricoxib by cosolvency approach. ISRN Physical Chemistry, 2012, 1–5. https://doi.org/10.5402/2012/820653
Parker, W. (1982). Alcohol-containing pharmaceuticals. American Journal of Drug and Alcohol Abuse, 9(2), 195–209.
Purnomo, H., Jenie, U. A., Nugroho, A. E., & Pranowo, H. D. (2016). In silico and in vivo qualitative relationships of para-aminophenol analogues. International Journal of Pharmaceutical and Clinical Research, 8(5), 367–371.
Rathi, P. B. (2010). Determination and evaluation of solubility parameter of satranidazole using dioxane-water system. Indian Journal of Pharmaceutical Sciences, 72(5), 671–674. https://doi.org/10.4103/0250-474X.78546
Rouaz, K., Chiclana-Rodríguez, B., Nardi-Ricart, A., Suñé-Pou, M., Mercadé-Frutos, D., Suñé-Negre, J. M., Pérez-Lozano, P., & García-Montoya, E. (2021). Excipients in the pediatric population: A review. Pharmaceutics, 13(3), 1–44. https://doi.org/10.3390/pharmaceutics13030387
Sánchez-Camargo, A. del P., Bueno, M., Parada-Alfonso, F., Cifuentes, A., & Ibáñez, E. (2019). Hildebrand solubility parameters for selection of green extraction solvents. Trends in Analytical Chemistry, 118, 227–237. https://doi.org/10.1016/j.trac.2019.05.046
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012). Drug Solubility: importance and enhancement techniques. ISRN Pharmaceutics, 2012(100 mL), 1–10. https://doi.org/10.5402/2012/195727
Solanki, S. S., Soni, L. K., & Maheshwari, R. K. (2013). Study on mixed solvency concept in formulation development of aqueous injection of poorly water-soluble drug. Journal of Pharmaceutics, 2013, 1–8. https://doi.org/10.1155/2013/678132
Strickley, R. G. (2004). Solubilizing excipients used in commercially available oral and injectable formulations. Pharmaceutical Research, 21(2), 201–230.
Tushar Saha, Tashnuva Rifat, & Shimanto, S. (2019). Prospects of Halal Pharmaceuticals. Asian Journal of Ethnopharmacology and Medical Foods, 5(2), 17–23.
Zuccotti, G. V., & Fabiano, V. (2011). Safety issues with ethanol as an excipient in drugs intended for pediatric use. Expert Opinion on Drug Safety, 10(4), 499–502. https://doi.org/10.1517/14740338.2011.565328
